Sansure Presented at MEDICA 2024 with the Latest IVD Solutions
From Nov 11 to 14 at Düsseldorf Exhibition Centre, Germany, Medica, the largest medical B2B trade fair in the world, has once again gathered experts and companies in the healthcare industry to share the advancing “Med Tech & Devices” and “Digital Health” solutions.
Among the exhibitors, Sansure, at booth Hall 3, Booth F96-5, has made a standout presentation with our latest IVD solutions.
Sansure’s IVD Testing Solutions at MEDICA 2024
To be your “Innovative Partner for Precise and Accessible Diagnosis”, the theme of our presentation this year at MEDICA 2024, we selected some of the kicking clinical and laboratory diagnostic instruments.
Molecular Solution
iPonatic III Pro:
The molecular POCT solution is a mobile nucleic acid diagnostic platform designed to deliver rapid and precise molecular testing beyond traditional lab settings. Compact and lightweight, it integrates fully automated nucleic acid extraction and amplification in a closed system. Sansure iPonatic series has been applied in diverse environments like community healthcare institutions, mobile clinics, and remote medical scenarios.
SureXler 48:
The real-time PCR instrument made its debut on the international stage.
It is set to revolutionize PCR diagnostics with its fast thermal system, completing amplification in just 30 minutes. Designed for high throughput and precision, it offers temperature uniformity at ±0.1°C and detects gene expression changes as low as 1.5-fold.
Supporting up to 8 detection channels, the utmost efficiency makes it the best helper in non-clinical sample testing, pathogen detection, and genetic screening. From qualitative analysis to high-resolution melting, SureXler 48 has them all covered.
Natch 16S:
The Natch 16S Nucleic Acid Extraction System is a compact, high-performance device designed for efficient DNA and RNA extraction with a throughput of 1 to 16 samples. Utilizing magnetic bead technology and 10 mixing modes, it offers quick extraction times of 10-60 minutes, making it ideal for fast-paced diagnostics in areas like women’s health, respiratory diseases, and public health.
Built for reliability, the Natch 16S features anti-contamination measures with a UV lamp and air filtration system, a user-friendly 7-inch touch screen, and a compact design for easy lab placement. With its pre-packaged magnetic bead extraction kit, it ensures consistency and ease of use. A great relief for modern healthcare services
Q-POC:
Q-POC PCR diagnostic platform is the result of the Sansure-QuantuMDx cooperation. It enables rapid, high-quality, and on-demand multiplex PCR testing with results in approximately 30 minutes. Its flexible design allows testing in any location.
Initially developed for SARS-CoV-2 detection, the PCR testing system has expanded capabilities that allow a new chemistry-based multiplex testing kit to run on the same cartridge.
Immunoassay Solution
Surelite 8:
Surelite 8 is a compact and highly sensitive chemiluminescence immunoassay (CLIA) system designed for single-sample, point-of-care (POC) testing. Weighing only 12 kg and offering an 8-channel parallel detection capacity, this easy-to-use instrument is ideal for quick, reliable diagnostics in a small, efficient footprint.
Besides, it is certified by EU IVDR and is designed for single-sample, fully automated chemiluminescence testing. With high sensitivity, stable results, and robust automation, it is ideal for diverse healthcare environments, from emergency rooms to clinics.
YnY 3030:
YnY 3030 comes with Sansure’s patented NRC (Neutral Ruthenium Complex) luminescent label, magnetic bead coupling, and electrochemical process control. The EECL system has 25 reagent positions, 60 sample slots, and built-in reagent refrigeration.
This system is ideal for a range of settings, including laboratory and emergency departments, delivering rapid results with an approximate turnaround time of 8 minutes for urgent samples.
On-Site Interaction with Exhibitors
At MEDICA 2024, Sansure hosted four expert-led presentations exploring cutting-edge solutions in diagnostics.
The presentation covered Sansure solutions on POC PCR testing, Disease X digital infectious disease, women and child health and blood-borne infection diagnostics, and immunological chronic disease diagnostic. These sessions highlighted emerging trends and Sansure’s strengths in various diagnostic fields.
On top of the lectures, a standout at the event was Sansure’s live demonstration of our rapid respiratory quad test, delivering results within 30 minutes from sampling, which captivated hundreds for visits.
Conclusion
Sansure has been committed to redefining precision and efficiency in healthcare diagnostics and enhancing accessibility for global communities. Stay tuned with us; let’s explore the potential of IVD solutions.
Last but not least, glad to be part of the grand exhibition. See you next time!
